Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine; prednisone and bortezomib (BPV)

被引：0
|
作者：
Poenisch, W. [1 ]
Mrachacz, H. [2 ]
Khoder, N. [3 ]
Ploetze, M. [3 ]
Holzvogt, B. [3 ]
Andrea, M. [3 ]
Schliwa, T. [3 ]
Heyn, S. [3 ]
Pfrepper, C. [4 ]
Franke, G. N. [3 ]
Krahl, R. [3 ]
Jentzsch, M. [3 ]
Leiblein, S. [3 ]
Schwind, S. [3 ]
Vucinic, V. [3 ]
Niederwieser, D. [3 ]
机构：
[1] Univ Klinikum Leipzig, Hamatol, Int Onkol, Leipzig, Germany
[2] Univ Klinikum Leipzig, Hamatol, Leipzig, Germany
[3] Univ Klinikum, Leipzig, Germany
[4] Diakonissen Hosp, Leipzig, Germany
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V43
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [41] A prospective study of bortezomib in combination with melphalan and prednisone for patients with previously untreated multiple myeloma.
    Gasparetto, C
    Keogh, GP
    Gockerman, JP
    Horwitz, M
    Moore, JO
    DeCastro, C
    Diehl, L
    Davis, P
    Chao, N
    Rizzieri, DA
    [J]. BLOOD, 2005, 106 (11) : 379B - 379B
  • [42] BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Kim, M. K.
    Kim, K.
    Yoon, D. H.
    Suh, C.
    Moon, J. H.
    Lee, Y. J.
    Lee, J. H.
    Jung, S. -H.
    Kim, H. J.
    Bae, S. H.
    Kim, J. S.
    Lee, J. -O.
    Eom, H. S.
    Lee, W. -S.
    Kang, H. J.
    Mun, Y. -C.
    Do, Y. R.
    Hyun, M. S.
    [J]. HAEMATOLOGICA, 2017, 102 : 793 - 793
  • [43] Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma
    Baz, Rachid
    Fanning, Suzanne
    Kunkel, Lori
    Gaballa, Sameh
    Karam, Mary Ann
    Reed, Janice
    Kelly, Megan
    Hussein, Mohamad
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2338 - 2344
  • [44] Daratumumab, Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in TransplantIneligible Patients with Newly Diagnosed Multiple Myeloma: Pooled Analysis of Octans and Alcyone
    Hou, Jian
    Fu, Weijun
    Bang, Soo-Mee
    Huang, Honghui
    Kim, Kihyun
    Li, Wei
    An, Gang
    Lee, Je-Jung
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, C. S.
    Rodriguez-Otero, Paula
    Dimopoulos, Meletios A.
    Fujisaki, Tomoaki
    Lee, Jae Hoon
    Wroblewski, Susan
    Carson, Robin
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Bin Jia
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Wang, Jianxiang
    [J]. BLOOD, 2021, 138
  • [45] Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma
    Facon, Thierry
    Lee, Jae Hoon
    Moreau, Philippe
    Niesvizky, Ruben
    Dimopoulos, Meletios
    Hajek, Roman
    Pour, Ludek
    Jurczyszyn, Artur
    Qiu, Lugui
    Klippel, Zandra
    Zahlten-Kumeli, Anita
    Osman, Muhtarjan
    Paiva, Bruno
    San-Miguel, Jesus
    [J]. BLOOD, 2019, 133 (18) : 1953 - 1963
  • [46] Prognostic impact of rapid reduction of involved free light chains during first line therapy with bendamustine, prednisone and bortezomib (BPV) in myeloma patients
    Holzhey, T.
    Poenisch, W.
    Wang, S. -Y.
    Holzvogt, M.
    Holzvogt, B.
    Zehrfeld, T.
    Hammerschmidt, D.
    Neumann, D.
    Hoffmann, F. -A
    Becker, C.
    Schwarzer, A.
    Schwarz, M.
    Reifenrath, K.
    Jentzsch, M.
    Schwind, S.
    Bill, M.
    Grimm, J.
    Platzbecker, U.
    Scholz, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 101 - 101
  • [47] Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma
    Kim, Min Kyoung
    Kim, Kihyun
    Yoon, Do Hyun
    Suh, Cheolwon
    Moon, Joon Ho
    Lee, Yoo Jin
    Lee, Jae Hoon
    Jung, Sung-Hoon
    Lee, Je-Jung
    Kim, Hyo Jung
    Bae, Sung Hwa
    Kim, Jin Seok
    Lee, Jeong-Ok
    Eom, Hyeon Seok
    Lee, Won-Sik
    Kang, Hye Jin
    Mun, Yeung-Chul
    Do, Young Rok
    Hyun, Myung Soo
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E70 - E70
  • [48] Stem cell mobilization and autologous stem cell transplantation after induction with bendamustine, prednisone and bortezomib (BPV) in 135 untreated myeloma patients with variable renal function
    Wang, Song-Yau
    Fricke, Susann
    Holzhey, Tanja
    Vucinic, Vladan
    Franke, Georg-Nikolaus
    Platzbecker, Uwe
    Merz, Maximilian
    Poenisch, Wolfram
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S129 - S129
  • [49] Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma in Chinese patients
    Cai, Zhen
    Zheng, Weiyan
    Wei, Guoqing
    Ye, Xiujin
    He, Jingsong
    Li, Li
    Wu, Wenjun
    Lin, Maofang
    [J]. BLOOD, 2007, 110 (11) : 281B - 281B
  • [50] Oral melphalan, prednisone and lenalidomide treatment for newly diagnosed elderly multiple myeloma patients
    Falco, F.
    MT, Petrucci
    Corradini, P.
    Crippa, C.
    Di Raimondo, F.
    Falcone, A.
    Guiliani, N.
    Musto, P.
    Ruggeri, M.
    Larocca, A.
    D'Agostino, F.
    Canepa, L.
    Gozzetti, A.
    Morabito, F.
    Knight, R.
    Zeldis, J. B.
    Boccadoro, M.
    Palumbo, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 31 - 31
12345